Jeremy Levin
Chief Executive Officer bei OVID THERAPEUTICS INC.
Vermögen: 11 Mio $ am 31.03.2024
Profil
Jeremy Max Levin is currently the Chairman, President & Chief Executive Officer at Ovid Therapeutics, Inc. He is also the Chairman at Opthea Ltd.
and serves as an Independent Director at H.
Lundbeck A and Director at Biotechnology Innovation Organization.
Additionally, he is an Advisor at New Rhein Healthcare Investors.
In his former positions, Dr. Levin served as the President & Chief Executive Officer at Teva Pharmaceutical Industries Ltd.
from 2012 to 2013.
He was also the Chairman & Chief Executive Officer at Cadus Corp.
from 1992 to 1998 and the Chief Executive Officer at Physiome Sciences, Inc. from 1998 to 2003.
He held various director roles at ZymoGenetics, Inc., Biocon Ltd., The Biotechnology Institute, New York Biotechnology Association, Inc., and ZappRx, Inc. He was the SVP-Strategy, Alliances & Transactions at Bristol Myers Squibb Co. from 2007 to 2012 and the Global Head-Strategic Alliances at Novartis Institutes for Biomedical Research, Inc. from 2002 to 2007.
Dr. Levin obtained his graduate and doctorate degrees from the University of Oxford.
He also received an undergraduate degree from the University of Oxford in 1974 and a doctorate degree from the University of Cambridge in 1981.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
OVID THERAPEUTICS INC.
5,17% | 18.03.2024 | 3 652 176 ( 5,17% ) | 11 Mio $ | 31.03.2024 |
OPTHEA LIMITED
0,00% | 21.12.2023 | 3 937 ( 0,00% ) | 1 901 $ | 31.03.2024 |
Aktive Positionen von Jeremy Levin
| Unternehmen | Position | Beginn |
|---|---|---|
| OVID THERAPEUTICS INC. | Chief Executive Officer | 01.03.2015 |
| H. LUNDBECK A/S | Director/Board Member | 01.03.2017 |
| OPTHEA LIMITED | Chairman | 05.10.2020 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | 14.06.2021 |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | President | 02.09.2009 |
New Rhein Healthcare Investors
 New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors LLC (New Rhein Healthcare Investors) is a private equity firm founded in 2010 by Parekh Greg. The firm is headquartered in Philadelphia, Pennsylvania. | Consultant / Advisor | - |
Ehemalige bekannte Positionen von Jeremy Levin
| Unternehmen | Position | Ende |
|---|---|---|
| BIOCON LIMITED | Director/Board Member | 01.01.2020 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Chief Executive Officer | 30.10.2013 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| ░░░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
Ausbildung von Jeremy Levin
| University of Oxford | Doctorate Degree |
| University of Cambridge | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 6 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| H. LUNDBECK A/S | Health Technology |
| OVID THERAPEUTICS INC. | Health Technology |
| OPTHEA LIMITED | Health Technology |
| BIOCON LIMITED | Health Technology |
| Private Unternehmen | 10 |
|---|---|
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Commercial Services |
Cadus Corp.
 Cadus Corp. BiotechnologyHealth Technology Cadus Corp. engages in the acquisition, renovation and construction of real estate. It intends to purchase individual homes or individual residential lots for purposes of renovation or construction and resale. The company was founded by Dana M. Fowlkes, James R. Broach, and Thomas Shenk on January 23, 1992 and is headquartered in New York, NY. | Health Technology |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Physiome Sciences, Inc.
 Physiome Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Physiome Sciences, Inc. provides computer-based modeling and simulation of cells, and biological systems for drug development. The company was founded by Donna Rounds and is headquartered in Princeton, NJ. | Commercial Services |
The Biotechnology Institute
 The Biotechnology Institute Miscellaneous Commercial ServicesCommercial Services The Biotechnology Institute is a non-profit organization, which engages in designing and managing programs about biotechnology research. Its programs include BioGENEius Challenges, leadership awards, and Adopt-A-School. The company was founded in 1998 and is headquartered in Washington, DC. | Commercial Services |
New York Biotechnology Association, Inc.
 New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | Commercial Services |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
ZappRx, Inc.
 ZappRx, Inc. Miscellaneous Commercial ServicesCommercial Services ZappRx, Inc. develops prescription and prior authorization platform services. It provides healthcare providers, specialty pharmacies, biopharmacies, and security standards solutions. The company was founded by Zoe Barry in 2012 and is headquartered in Boston, MA. | Commercial Services |
New Rhein Healthcare Investors
New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors LLC (New Rhein Healthcare Investors) is a private equity firm founded in 2010 by Parekh Greg. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
